Home

Ishita Drugs & Industries Ltd PE Ratio

Image

Ishita Drugs & Industries Ltd

NSE: ISHITADRUGS

PE

27.7

Last updated on: Apr 19, 2025

Key Highlights

  • The P/E Ratio of Ishita Drugs & Industries Ltd is 27.7 as of 19 Apr 9.00 AM .
  • The P/E Ratio of Ishita Drugs & Industries Ltd changed from 6 on March 2020 to 26.2 on March 2024 . This represents a CAGR of 34.29% over 5 years.
  • The Latest Trading Price of Ishita Drugs & Industries Ltd is ₹ 79.9 as of 17 Apr 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.9. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Ishita Drugs & Industries Ltd

No data available

Company Fundamentals for Ishita Drugs & Industries Ltd

Image

Ishita Drugs & Industries Ltd

NSE: ISHITADRUGS

Share Price

₹ 79.9

-0.10 (-0.13%)

stock direction

Last updated on: Apr 17, 2025

Market Price of Ishita Drugs & Industries Ltd

1M

1Y

3Y

5Y

Monitoring Ishita Drugs & Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Apr 202579.9
16 Apr 202580
15 Apr 202580.11
11 Apr 202582.3
09 Apr 202582.67
08 Apr 202581.11
07 Apr 202582.83
04 Apr 202581.07
03 Apr 202584.61
02 Apr 202585.18

BlinkX Score for Ishita Drugs & Industries Ltd

Asset Value vs Market Value of Ishita Drugs & Industries Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Ishita Drugs & Industries Ltd23.89
Sun Pharmaceutical Industries Ltd420136
Divis Laboratories Ltd149680
Cipla Ltd122390
Torrent Pharmaceuticals Ltd110154
Mankind Pharma Ltd106555

PE Ratio of Ishita Drugs & Industries Ltd Explained

23.89

Market cap

0

Earnings

27.7X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Ishita Drugs & Industries Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Ishita Drugs & Industries Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Ishita Drugs & Industries Ltd

No data available

* All values are in %

About Ishita Drugs & Industries Ltd

  • Ishita Drugs & Industries Limited was incorporated in Feb.'92 by Jagdish Agarwal.
  • The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient.
  • It has a state-of-art manufacturing facility, in terms of reaction capabilities, quality control and environmental safety.
  • The plant has been designed and constructed to meet GMP norms. The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad.
  • Buoyed by the growth of its first Venture, the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat, to cater to the need of Pharma industry for Quality Products.

Ishita Drugs & Industries Ltd News Hub

Ishita Drugs & Industries standalone net profit rises 7.14% in the June 2024 quarter

Net profit of Ishita Drugs & Industries rose 7.14% to Rs 0.15 crore in the quarter ended June 2024 a

Read more

14 Aug 24

Ishita Drugs & Industries to declare Quarterly Result

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 13 August

Read more

10 Aug 24

Ishita Drugs & Industries AGM scheduled

Ishita Drugs & Industries announced that the Annual General Meeting (AGM) of the company will be hel

Read more

28 Aug 24

Ishita Drugs & Industries standalone net profit declines 9.52% in the September 2024 quarter

Net profit of Ishita Drugs & Industries declined 9.52% to Rs 0.19 crore in the quarter ended Septemb

Read more

13 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Ishita Drugs & Industries Ltd

What is the current PE Ratio of Ishita Drugs & Industries Ltd?

The Current PE Ratio of Ishita Drugs & Industries Ltd is 27.74 as on 19 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 19 Apr 2025.

What was the PE Ratio of Ishita Drugs & Industries Ltd last year?

The PE Ratio of Ishita Drugs & Industries Ltd was 25.61 last year, now the PE ratio is 27.74, showing a year-on-year growth of 8.3%.

What does the PE Ratio of Ishita Drugs & Industries Ltd indicate about its stock?

The PE Ratio of Ishita Drugs & Industries Ltd is 27.74. This ratio indicates that investors are willing to pay 27.74 times the earnings per share for each share of Ishita Drugs & Industries Ltd.

What is the PE Ratio Growth of Ishita Drugs & Industries Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Ishita Drugs & Industries Ltd grew by 8.3% whereas, the EPS ratio grew by 23.1.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions